Cód QR

Evaluation of the risk of developing hepatocellular carcinoma in chronic Hepatitis C patients receiving antiviral treatment

Introduction: Chronic HC leads to the development of liver cirrhosis (LC) and hepatocellular carcinoma (HCC). The treatment of chronic HC with DAAs reduces mortality from LC and HCC. The study aimed to investigate the serological markers specific to HCC (PIVKA-II and AFP) in patients with chronic H...

Cur síos iomlán

Sábháilte in:
Príomhchruthaitheoirí: Sona Sargsyan, Hripsime Magdesieva, Tsoghik Navoyan, Aregnaz Mkhitaryan, Lusine Atoyan, Violeta Sargsyan, Hayk Harutyunyan, Vahe Azatyan, Armine Minasyan, Naira Gyulazyan
Formáid: Artigo
Teanga:Inglês
Foilsithe / Cruthaithe: The Journal of Infection in Developing Countries 2024-05-01
Sraith:Journal of Infection in Developing Countries
Ábhair:
Chronic HCV infection
hepatocellular carcinoma
liver cirrhosis
direct-acting antiviral agents
Rochtain ar líne:https://jidc.org/index.php/journal/article/view/18410
Clibeanna: Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla